Filing Overview
The filing is a Form 6-K furnished by China Jo-Jo Drugstores, Inc., a Cayman Islands company and foreign private issuer. It covers December 2022 and was signed on December 21, 2022. The filing metadata identifies the company as Ridgetech Inc., but the filing text identifies the registrant as China Jo-Jo Drugstores, Inc.
Material Corporate Action
On December 19, 2022, the compensation committee granted 2,150,000 restricted stock awards under the Company’s Second Amended and Restated 2010 Equity Incentive Plan. The filing states that vesting conditions were waived.
- Lei Liu, Chief Executive Officer and director: 250,000 ordinary shares.
- Li Qi, director: 200,000 ordinary shares.
- Non-executive management employees: 1,700,000 ordinary shares.
Financial Metrics and Liquidity
The filing text does not provide revenue, profit, cash flow, margins, debt, liquidity, balance sheet data, or other operating or financial metrics.
Guidance, Outlook, and Risks
The filing provides no guidance, outlook, management commentary, contingencies, risk updates, or unusual items beyond the restricted stock awards.
Key Investor Verification Items
- Confirm the registrant’s identity, because the request metadata names Ridgetech Inc. while the filing names China Jo-Jo Drugstores, Inc.
- Verify the accounting treatment, dilution impact, and fair value of the 2,150,000 restricted stock awards.
- Review subsequent filings for the effect of the awards on shares outstanding and equity compensation expense.
- Confirm the stated waiver of vesting conditions and whether any additional terms or restrictions apply.